ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO531

Evidence of Circadian Rhythm of Plasma Activin A, Its Disturbance by CKD, and Contribution of Activin A Secreted from Injured Kidney

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic

Authors

  • Nordholm, Anders, Herlev Hospital, Copenhagen, Denmark
  • Egstrand, Søren, Herlev Hospital, Copenhagen, Denmark
  • Mace, Maria Lerche, Herlev Hospital, Copenhagen, Denmark
  • Morevati, Marya, Rigshospitalet, Copenhagen, Denmark
  • Olgaard, Klaus, Rigshospitalet, Copenhagen, Denmark
  • Lewin, Ewa, Herlev Hospital, Copenhagen, Denmark
Background

Activin A is an interesting new factor in CKD-MBD. It is a member of the TGF-β family, essential in kidney development and repair. Increased systemic activin A might be a biomarker of CKD-MBD that can be targeted for CKD-MBD prevention and therapy. Disrupted circadian rhythm (CR) causes detrimental health effects and CRs are observed in mineral metabolism. Our hypothesis is that increase in circulating levels of activin A is associated with disruption of circadian rhythm of plasma activin A, and parameters of mineral homeostasis in CKD.

Methods

CRs of activin A (pg/ml), FGF23 (pg/ml), PTH (pg/ml) and P (mM) were measured every 6th hour in control (Ctr) and CKD rats (5/6 nephrectomy) on low (LP), standard (SP), and high phosphate (HP) diet (N=8-26). Isolated renal vein and artery sampling was performed in kidney injury rats (14 days unilateral ureter obstruction, UUO) and healthy Ctr.

Results

Activin A was 2.5-fold higher in renal vein compared to artery in UUO (V:246±22, A:100%, p<0.05) but unaltered in Ctr (V:100±6, A:100%, ns) indicating renal secretion in kidney injury.
Plasma activin A exhibited CR in Ctr (p<0.01 by cosinor analysis) with 300% higher values at acrophase (437±59) compared to nadir (106±7) (p<0.05). CKD obliterated the CR of activin A. Plasma FGF23 showed CR in Ctr (p<0.05) with peak at 14:00 (877±42), while the CR was obliterated in CKD rats on LP and SP even though FGF23 was suppressed in CKD LP (p<0.05). In CKD HP FGF23 was increased (p<0.01) and the CR was disturbed with shift in acrophase to 09:00 (4173±316). Plasma PTH exhibited CR in Ctr (p<0.0001), while the rhythm was disturbed in CKD (p<0.05) despite prevention of sHPT in CKD LP (p<0.05). Plasma P showed CR in all groups (p<0.05). However, the CR was disturbed in all CKD groups with shift in acrophase from 16:00 in Ctr to 19:00 (LP), 17:00 (SP), and 00:00 (HP).

Conclusion

Existence of a circadian rhythm of circulating activin A is established for the first time. The rhythmicity of activin A is disturbed in CKD rats and is associated with disturbed circadian rhythms of P and P regulating hormones PTH and FGF23. In injured kidney activin A is induced and secreted to venous effluent which can contribute to the disturbed circadian rhythm of activin A in uremia.